Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
about
The gene for human TATA-binding-protein-associated factor (TAFII) 170: structure, promoter and chromosomal localizationGenes other than BRCA1 and BRCA2 involved in breast cancer susceptibilityPTEN deficiency: a role in mammary carcinogenesis.PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signalingGenetic predisposition to breast cancer: a surgical perspective.Characterization of a novel PTEN mutation in MDA-MB-453 breast carcinoma cell lineClinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatmentScreening for germline phosphatase and tensin homolog-mutations in suspected Cowden syndrome and Cowden syndrome-like families among uterine cancer patients.Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast EnglandAllelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma.PTEN mutation, methylation and expression in breast cancer patients.Targeting the PI3-kinase/Akt/mTOR signaling pathway.New phosphatidylinositol 3-kinase inhibitors for cancer.MicroRNA-142-5p induces cancer stem cell-like properties of Cutaneous Squamous Cell Carcinoma via inhibiting PTEN.Analysis of genes involved in the PI3K/Akt pathway in radiation- and MNU-induced rat mammary carcinomasGermline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancer.Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen.Regulation of Signal Transduction by DJ-1.
P2860
Q24531921-59A919C6-0EF7-4B12-A835-67F63CB59B31Q24679438-132BC280-43D9-4A7B-B738-525BC291D4ACQ24801835-82E8F9B8-A72B-407E-BD2E-1C1B712D7CCDQ28253621-0475B3CF-CA42-4627-83B7-0131F6989E7AQ33836065-CD8AB753-36E5-49B1-AE94-6B28BCC7078FQ34079578-548D9A5B-E902-4BE1-952F-117026A7C4F2Q34508976-C6482215-66C0-4BD5-90CA-947174B600D0Q35167887-A22F2622-AE93-44E1-B1E0-7D0C5E59472EQ36622589-95E9B666-3992-4EF8-9DE8-4965F16248DBQ36622783-D4342598-F5E4-449A-AFA1-B7987EADC477Q37092758-3D66BFBD-00E0-40BD-8E7D-DB4C5C217FA1Q37265126-4ADBF8C1-1CC1-4B99-B7F7-CA909FE42EEEQ37851994-0B50E0D4-93A6-431F-A598-80D9F27ECABAQ38600615-B254A643-3BE4-4808-A05C-AEBEBBAD8E20Q41520909-11B44FA8-C3A5-42A0-AE8C-369DDC286F11Q44173483-912EF197-3FE4-4095-80D1-6D2CFF7E2F98Q45099758-489A9AE4-3B82-4767-A3DD-A6B65D47F7B9Q47393112-B0A172E7-6515-4ECE-A3FE-91F883E31BE2
P2860
Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
@ast
Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
@en
type
label
Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
@ast
Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
@en
prefLabel
Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
@ast
Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
@en
P2093
P2860
P50
P356
P1476
Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
@en
P2093
A von Deimling
D Freihoff
O D Wiestler
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690121
P407
P577
1999-02-01T00:00:00Z